In a subsequent expansion study, 14 of 102 (13.7%) ACC patients’ samples sequenced were found to harbour NOTCH1 activating mutations in the T-ALL hotspots i.e., the HD and PEST domain [82]. This evidence concerns the gene NOTCH1 and adrenal cortex carcinoma.